Recent Research Articles
A Clinician’s Perspective on Antioxidant Use During Chemotherapy for Breast Cancer: Exploring the Evidence
Master herbalist and clinical nutritionist Donnie Yance explores the research and shares his perspective on the use of botanicals and antioxidants during chemotherapy treatment for those with breast cancer.
Listen to Glenn Sabin interviewed on the influential Relentless Health Value podcast on the topic of integrative oncology in hospital and health system settings. Host Stacey Richter and Glenn discuss the growing science supporting integrative oncology and the profound opportunity for hospitals and cancer centers to engage and educate their communities on true cancer prevention focused on smart lifestyle—read: beyond vaccines, colonoscopies, mammograms and early detection.
There is good news in the advancement of chemo-free approaches to managing chronic lymphocytic leukemia, and I am thrilled to share it with you. Results of the phase III ECOG trial found that the combination of ibrutinib (Imbruvica) plus rituximab (Rituxan) came out superior to the chemotherapy and immunotherapy (chemoimmunotherapy) grouping of fludarabine, cyclophosphamide, and rituximab, known as FCR.
Glenn shares how THC and CBD are being used in a clinical setting—and where we are in terms of current science supporting medical marijuana and CBD oil for symptom relief and as an anticancer agent. He also shares his own history with cannabinoids.
Glenn explores the phenomena of cancer outliers, exceptional responders and radical remissions in the age of precision medicine, biomedical informatics and integrative oncology.
A recently published paper in the esteemed JAMA Oncology triggered dire headlines, including this one in The New York Times:
“People who used herbs, acupuncture and other complementary treatments tended to die earlier than those who didn’t.”
Really? Is this true?
For 20 years, the Environmental Working Group (EWG) has been the stalwart investigative organization scrutinizing unsafe chemicals and toxins in our food, water, cosmetics, and cleaning products.
Given the easy access to direct-to-consumer (DTC) DNA testing, it is vital to discern the potential value versus possible emotional and physical risks that having such data might present.
It is widely acknowledged that 80% of our immune system resides in our gut. Therefore, healthy microbiota—bio-diverse gut flora comprised of healthy strains of bacteria—may offer a powerful key to preventing disease, including cancer. Turns out, a healthy microbiome may also significantly enhance the treatment outcomes of anticancer agents, most notably novel targeted immunotherapies.
The Right-to-Try movement—advocates for faster access to potentially life-saving experimental drugs for terminal patients—has gained strong momentum, with the act recently winning easy passage in congress, and, at the time of this article, it is on its way for a senate vote. The legislation is widely anticipated to become law later this year. As of […]